No insider purchase over the last 90 days. The latest, by Nicola Blackwood, was filed 22 Jan 2026.
RTW Biotech Opportunities Ltd: what insiders have been doing
RTW Biotech Opportunities Ltd is a Banks company. Its directors and officers file their transactions with RNS (LSE). The last twelve months, up to 21 October 2026, brought 1 filing signed by 1 insider.
No insider sold shares on the market over the period. Instead, the filings list 1 purchase, made by 1 insider. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 1 senior executive.
Across the 832 companies tracked on its exchange, the median is 6 filings; at 1 filing, this issuer sits below that mark. Since 2020, the database holds 21 purchases and no sales by insiders of the company.
The last insider purchase was made public on 22 January 2026, 290 days ago.
For comparison within the same sector, see the insider buying recorded at Dynex Capital Inc and First Guaranty Bancshares, Inc. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- +82.9%Entry US$1.17 · Close at T+365 US$2.14
- +80.0%Entry US$1.15 · Close at T+365 US$2.07
- +0.7%Entry US$1.35 · Close at T+365 US$1.36
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 0London Stock ExchangeISIN GG00BKTRRM22RNS:2ee2a6e0-5070-49e2-8052-32f84888ae62Canonical exit: 4 Jan 2026 (T+90)
- 15,000 shares@ £1.148923.9% of flowLondon Stock ExchangeISIN GG00BKTRRM22RNS:5679768Canonical exit: 31 Aug 2025 (T+90)
- 50,000 shares@ £1.14100.0% of flowLondon Stock ExchangeISIN GG00BKTRRM22RNS:5612880Canonical exit: 9 Jul 2025 (T+90)
- 40,000 shares@ £1.34976.1% of flowLondon Stock ExchangeISIN GG00BKTRRM22RNS:5539935Canonical exit: 15 May 2025 (T+90)
- 50,000 shares@ £1.322100.0% of flowLondon Stock ExchangeISIN GG00BKTRRM22RNS:5077677Canonical exit: 22 May 2024 (T+90)
- 10,000 shares@ US$1.182.0% of flowLondon Stock ExchangeISIN GG00BKTRRM22FCA-NSM:4622087Canonical exit: 21 Mar 2023 (T+90)
- 25,000 shares@ US$1.0297100.0% of flowLondon Stock ExchangeISIN GG00BKTRRM22FCA-NSM:4596461Canonical exit: 28 Feb 2023 (T+90)
- 50,000 shares@ US$1.10518.6% of flowLondon Stock ExchangeISIN GG00BKTRRM22FCA-NSM:4569600Canonical exit: 2 Feb 2023 (T+90)
- 25,622 shares@ US$1.1499.7% of flowLondon Stock ExchangeISIN GG00BKTRRM22FCA-NSM:4565106Canonical exit: 29 Jan 2023 (T+90)
- 50,000 shares@ US$1.2027.9% of flowLondon Stock ExchangeISIN GG00BKTRRM22FCA-NSM:4517377Canonical exit: 20 Dec 2022 (T+90)
- 50,000 shares@ US$1.3435London Stock ExchangeISIN GG00BKTRRM22FCA-NSM:4327351Canonical exit: 30 Jun 2022 (T+90)
- 236,996 shares@ US$1.92London Stock ExchangeISIN GG00BKTRRM22FCA-NSM:4115907Canonical exit: 16 Dec 2021 (T+90)
- 50,000 shares@ US$1.90London Stock ExchangeISIN GG00BKTRRM22FCA-NSM:4083267Canonical exit: 14 Nov 2021 (T+90)
- 25,000 shares@ US$1.90London Stock ExchangeISIN GG00BKTRRM22FCA-NSM:4083262Canonical exit: 14 Nov 2021 (T+90)
- 25,000 shares@ US$2.12London Stock Exchange, Specialist Fund SegmentISIN GG00BKTRRM22FCA-NSM:3855872Canonical exit: 25 Apr 2021 (T+90)
- 494,004 sharesLondon Stock Exchange, Specialist Fund SegmentISIN GG00BKTRRM22FCA-NSM:3828301
- 100,000 shares@ US$1.8427100.0% of flowLondon Stock Exchange, Specialist Fund SegmentISIN GG00BKTRRM22FCA-NSM:3826424Canonical exit: 22 Mar 2021 (T+90)
- 169,000 sharesLondon Stock Exchange, Specialist Fund SegmentISIN GG00BKTRRM22FCA-NSM:3824934
- 169,000 shares@ US$1.165London Stock Exchange, Specialist Fund SegmentISIN GG00BKTRRM22FCA-NSM:3578494Canonical exit: 26 Jul 2020 (T+90)
- 57,000 shares@ US$1.165London Stock Exchange, Specialist Fund SegmentISIN GG00BKTRRM22FCA-NSM:3578483-0Canonical exit: 23 Jul 2020 (T+90)
- 100,000 shares@ US$1.165London Stock Exchange, Specialist Fund SegmentISIN GG00BKTRRM22FCA-NSM:3578483-1Canonical exit: 23 Jul 2020 (T+90)
- 50,000 shares@ US$1.165London Stock Exchange, Specialist Fund SegmentISIN GG00BKTRRM22FCA-NSM:3578483-2Canonical exit: 23 Jul 2020 (T+90)
- 50,000 shares@ US$1.0397London Stock Exchange, Specialist Fund SegmentISIN GG00BKTRRM22FCA-NSM:3566403Canonical exit: 28 Jan 2020 (T+90)
23 of 23 declarations
About RTW Biotech Opportunities Ltd
RTW Biotech Opportunities Ltd is an investment company focused on the biotechnology sector. It aims to generate returns by investing in innovative companies within this field.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
